Decision-making and experience of tamoxifen as chemoprevention to manage breast cancer risk for young women with a BRCA1/2 mutation

被引：0
|
作者：
Forrest, L. E. [1 ]
Shepherd, R. Forbes [1 ]
Young, M. [2 ]
Keogh, L. A. [3 ]
James, P. A. [1 ]
机构：
[1] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[2] Garvan Inst Med Res, Sydney, NSW, Australia
[3] Univ Melbourne, Melbourne, Vic, Australia
来源：
EUROPEAN JOURNAL OF HUMAN GENETICS | 2019年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
EMP1.24D
引用
收藏
页码：721 / 721
页数：1
相关论文
共 50 条
  • [41] A qualitative study on decision-making about BRCA1/2 testing in Italian women
    Battistuzzi, Linda
    Franiuk, Marzena
    Kasparian, Nadine
    Rania, Nadia
    Migliorini, Laura
    Varesco, Liliana
    EUROPEAN JOURNAL OF CANCER CARE, 2019, 28 (05)
  • [42] Preferences for breast cancer prevention among women with a BRCA1 or BRCA2 mutation
    Carol A. Mansfield
    Kelly A. Metcalfe
    Carrie Snyder
    Geoffrey J. Lindeman
    Joshua Posner
    Sue Friedman
    Henry T. Lynch
    Steven A. Narod
    D. Gareth Evans
    Alexander Liede
    Hereditary Cancer in Clinical Practice, 18
  • [43] Management of women with BRCA1/2 mutation-associated breast cancer
    Bayraktar, Soley
    Gluck, Stefan
    BREAST CANCER MANAGEMENT, 2012, 1 (02) : 157 - 164
  • [44] Prospective study of breast cancer risk for mutation negative women from BRCA1 or BRCA2 mutation positive families
    S. L. Harvey
    R. L. Milne
    S. A. McLachlan
    M. L. Friedlander
    K. E. Birch
    P. Weideman
    D. Goldgar
    J. L. Hopper
    K. A. Phillips
    Breast Cancer Research and Treatment, 2011, 130 : 1057 - 1061
  • [45] Prospective study of breast cancer risk for mutation negative women from BRCA1 or BRCA2 mutation positive families
    Harvey, S. L.
    Milne, R. L.
    McLachlan, S. A.
    Friedlander, M. L.
    Birch, K. E.
    Weideman, P.
    Goldgar, D.
    Hopper, J. L.
    Phillips, K. A.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 130 (03) : 1057 - 1061
  • [46] The risk of breast cancer in women with a BRCA1 mutation from North America and Poland
    Lubinski, Jan
    Huzarski, Tomasz
    Byrski, Tomasz
    Lynch, Henry T.
    Cybulski, Cezary
    Ghadirian, Parviz
    Stawicka, Malgorzata
    Foulkes, William D.
    Kilar, Ewa
    Kim-Sing, Charmaine
    Neuhausen, Susan L.
    Armel, Susan
    Gilchrist, Dawna
    Sweet, Kevin
    Gronwald, Jacek
    Eisen, Andrea
    Gorski, Bohdan
    Sun, Ping
    Narod, Steven A.
    INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (01) : 229 - 234
  • [47] Breast cancer risk in Chinese women with BRCA1 or BRCA2 mutations
    Lu Yao
    Jie Sun
    Juan Zhang
    Yingjian He
    Tao Ouyang
    Jinfeng Li
    Tianfeng Wang
    Zhaoqing Fan
    Tie Fan
    Benyao Lin
    Yuntao Xie
    Breast Cancer Research and Treatment, 2016, 156 : 441 - 445
  • [48] Breast cancer risk in Chinese women with BRCA1 or BRCA2 mutations
    Yao, Lu
    Sun, Jie
    Zhang, Juan
    He, Yingjian
    Ouyang, Tao
    Li, Jinfeng
    Wang, Tianfeng
    Fan, Zhaoqing
    Fan, Tie
    Lin, Benyao
    Xie, Yuntao
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 156 (03) : 441 - 445
  • [49] Pregnancy and breast cancer risk in women with BRCA1 or BRCA2 mutations
    Carol Lovegrove
    Nature Clinical Practice Oncology, 2006, 3 (1): : 9 - 9
  • [50] Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer
    Kuschel, B
    Lux, MP
    Goecke, TO
    Beckmann, MW
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2000, 9 (03) : 139 - 150
12345